Intrinsic Value of S&P & Nasdaq Contact Us

Prothena Corporation plc PRTA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • IE • USD

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$25.80
+138.4%

Stock Statistics — PRTA

Prothena Corporation plc (PRTA) has a market capitalization of $582.47M and trades at $10.82. The 52-week range is 4.32-11.69.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.4, Earnings Per Share (EPS) of $-4.53, annual revenue of $9.68M.

The stock has a beta of -0.28, operates in the Healthcare sector.

Trading Data
Current Price$10.82
52-Week Range4.32-11.69
Volume368.72K
Avg Volume (30D)511.27K
Market Cap$582.47M
Beta (1Y)-0.28
Company
IPO Date2012-12-18
Employees163
CEOGene G. Kinney
CountryIE
ExchangeNASDAQ Global Select
CurrencyUSD
ISINIE00B91XRN20
CUSIPG72800108
Income (Latest Year)
Revenue$9.68M
Gross Profit$5.98M
EBITDA$-197.13M
Operating Income$-184.56M
Net Income$-244.09M
EPS$-4.53
EPS Diluted$-4.53
Shares Outstanding$53.83M
Balance Sheet (Latest Year)
Total Assets$326.8M
Current Assets$315.19M
Cash & ST Investments$307.53M
Total Liabilities$46.33M
Total Debt$13.86M
Net Debt$-293.67M
Total Equity$280.47M
Debt / Equity0.05
Valuation Ratios
P/E Ratio-2.4
P/S Ratio60.15
P/B Ratio2.08
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message